These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10393897)
21. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105 [TBL] [Abstract][Full Text] [Related]
22. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Xue S; Perlman S Virology; 1997 Nov; 238(1):68-78. PubMed ID: 9375010 [TBL] [Abstract][Full Text] [Related]
23. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens. Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701 [TBL] [Abstract][Full Text] [Related]
25. Establishment of MHV-A59 S protein specific cytotoxic T lymphocyte clones. Kyuwa S; Stohlman SA Adv Exp Med Biol; 1993; 342():471-2. PubMed ID: 7516111 [No Abstract] [Full Text] [Related]
26. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants. Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270 [TBL] [Abstract][Full Text] [Related]
27. The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- Mice. Miura TA; Travanty EA; Oko L; Bielefeldt-Ohmann H; Weiss SR; Beauchemin N; Holmes KV J Virol; 2008 Jan; 82(2):755-63. PubMed ID: 18003729 [TBL] [Abstract][Full Text] [Related]
28. Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence. MacNamara KC; Chua MM; Phillips JJ; Weiss SR J Virol; 2005 Jul; 79(14):9108-18. PubMed ID: 15994805 [TBL] [Abstract][Full Text] [Related]
30. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. Williams RK; Jiang GS; Snyder SW; Frana MF; Holmes KV J Virol; 1990 Aug; 64(8):3817-23. PubMed ID: 2164599 [TBL] [Abstract][Full Text] [Related]
31. Induction of a protective immune response to murine coronavirus with non-internal image anti-idiotypic antibodies. Yu M; Talbot PJ Adv Exp Med Biol; 1995; 380():165-72. PubMed ID: 8830474 [TBL] [Abstract][Full Text] [Related]
32. MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity. Oleszak EL; Perlman S; Leibowitz JL Virology; 1992 Jan; 186(1):122-32. PubMed ID: 1309271 [TBL] [Abstract][Full Text] [Related]
33. Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice. Barthold SW; Smith AL Lab Anim Sci; 1990 Mar; 40(2):133-7. PubMed ID: 2157090 [TBL] [Abstract][Full Text] [Related]
34. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835 [TBL] [Abstract][Full Text] [Related]